Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

Matriptase is crucial for skin, hair, and immune cell health, and its imbalance can lead to cancer.

Signaling pathways are key targets for developing effective drugs.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

There are two ways to start hair growth: one needs Stat3 and the other does not, but both need PI3K activation.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

New therapies are being developed that target integrin pathways to treat various diseases.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Pyruvate Kinase M2 helps hair grow by linking energy production and a key hair growth pathway.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Using drugs to activate the Wnt/β-catenin pathway has potential for treating diseases but also presents challenges.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Three genes, BMP4, POSTN, and WNT5A, may help treat keloids.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

FTase and GGTase-I are essential for skin keratinocyte health.

Phaeodactylum tricornutum extract helps hair follicle cells grow by activating the ERK1/2 pathway.

Human tissue kallikreins help regulate skin barrier functions and affect skin health.

ZPK helps skin cells mature and may affect skin health.

Keratin 15 expression in skin cells is regulated by two mechanisms involving PKC/AP-1 and FOXM1.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.